Results 281 to 290 of about 821,521 (329)

Correlations of oxidative stress markers with niacin sensitivity in male patients with chronic schizophrenia. [PDF]

BMC Psychiatry
Yang M, Tian Q, Yuan X, Liu D, Shi Q, Yang H, Zhang X.   +6 more
europepmc   +1 more source

Clinically Significant Neuroimaging Findings Among Pediatric Patients Presenting to the Emergency Department With Symptoms of Psychosis: A Multicenter Retrospective Study

Academic Emergency Medicine, EarlyView.
ABSTRACT Background The clinical utility of diagnostic neuroimaging for pediatric patients presenting to the emergency department (ED) for psychosis remains unclear. We sought to estimate the prevalence of and characteristics associated with clinically significant neuroimaging findings among pediatric patients presenting to the ED with symptoms of ...
Jennifer A. Hoffmann, Tapan K. Parikh, Doug Lorenz, Michael P. Goldman, Emily M. Powers, Shilpa J. Patel, Ilana S. Lavina, Theodore W. Heyming, Jasmin T. England, Mohsen Saidinejad, Ilene Claudius, Pallavi Ghosh, Daniel J. Shapiro, Tricia B. Swan, Kamali L. Bouvay, Eileen Murtagh Kurowski, Nadine M. Smith, Justin R. Davis, Alexander B. Moxam, Eli J. Muhrer, Rohit P. Shenoi, Elyse N. Portillo, Ron L. Kaplan, Neil G. Uspal, Robert M. Lapus, Andrea T. Vo, Daniel B. Fenster, Danielle B. Barrocas, Deborah R. Liu, Pradip P. Chaudhari, Rachel Cafferty, Stephen B. Freedman, Jerri A. Rose, Megan F. Evers, Ashley M. Metcalf, Fareed Saleh, Jennifer Dunnick, Raymond D. Pitetti, Yashas R. Nathani, Muhammad Waseem, Todd A. Florin, on behalf of the Pediatric Emergency Medicine Collaborative Research Committee (PEMCRC) Psychosis Study Group   +41 more
wiley   +1 more source

Enhanced hybrid deep neural network for EEG-based schizophrenia diagnosis using functional and temporal features. [PDF]

Sci Rep
Soltani-Nejad M, Salar-Pour F, Rakhshan SA, Nezamabadi-Pour H.   +3 more
europepmc   +1 more source

Evaluation of glycine treatment for reducing alcohol craving and self‐administration in individuals with alcohol use disorder: A human laboratory trial

Alcohol, Clinical and Experimental Research, EarlyView.
This RCT evaluated whether the glycine receptor (GlyR) agonist glycine reduces craving and alcohol intake in individuals with AUD. Despite a preclinical rationale for targeting the GlyR, these parameters were not reduced. Interestingly, glycine weakened the link between alcohol‐induced craving and self‐administration, and baseline glycine levels were ...
Yasmin Olsson, Helga Lidö, Mia Ericson, Bo Söderpalm   +3 more
wiley   +1 more source

Cognitive deficits in individuals with comorbid personality disorder and schizophrenia: A scoping review. [PDF]

Schizophr Res Cogn
Chalut A, Potvin S, Iozzino L, Binette MA, Fiset-Renaud H, Chabake SA, Lecomte T.   +6 more
europepmc   +1 more source

Regional cerebellum volume anomalies and associated cognitive function in children with fetal alcohol spectrum disorders

Alcohol, Clinical and Experimental Research, EarlyView.
Prenatal alcohol exposure (PAE) significantly impacts cerebellum development, which may affect cognitive function in fetal alcohol spectrum disorders (FASD). Using an advanced MRI volumetric method that characterizes detailed cerebellum structure, this study identified regional cerebellum volume anomalies in children with FASD age 8–17 years ...
Blake A. Gimbel, Donovan J. Roediger, Kent A. Tuominen, Mary E. Anthony, Alexandra L. Doughty, Abigail M. Ernst, Bryon A. Mueller, Erik de Water, the CIFASD, Jeffrey R. Wozniak   +9 more
wiley   +1 more source

Does Adjuvant Metformin Reduce Olanzapine-Induced Metabolic Adverse Effects in Patients Diagnosed With Schizophrenia. [PDF]

Neuropsychopharmacol Rep
Butt A, Sadiq S.
europepmc   +1 more source

Effects of cannabidiol in alcohol use disorder patients with and without co‐occurring post‐traumatic stress disorder: Tolerability but no evidence for efficacy in two randomized proof‐of‐concept trials

Alcohol, Clinical and Experimental Research, EarlyView.
Two small placebo‐controlled trials evaluated the effects of cannabidiol (CBD) in patients with alcohol use disorder (AUD), with and without co‐occurring post‐traumatic stress disorder (PTSD). CBD was rapidly absorbed and generally well tolerated in dosages of up to 1200 mg/day. Both treatment groups showed large reductions in drinking.
Michael P. Bogenschutz, Esther Blessing, Danielle Dgheim, Dayeon Cho, Jun Zhang, Eugene M. Laska, Charles R. Marmar   +6 more
wiley   +1 more source

Changed expression of placental transporters and disrupted epigenetic patterns in a rat model of schizophrenia. [PDF]

Front Pharmacol
Szatmári P, Seres-Bokor A, Sztojkov-Ivanov A, Kékesi G, Horváth G, Ducza E.   +5 more
europepmc   +1 more source

Formulating Cognitive Functioning to Guide Personalised Treatment for People Diagnosed With Mental Disorders

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Objective and subjective cognitive impairment are highly prevalent in mental disorders and transdiagnostic phenomena. Cognitive impairment is associated with poorer functional outcomes and therefore requires treatment, but little guidance is available for clinicians.
Kelly Allott, Shayden Bryce, Katie Douglas, Alexandra Stainton, Stephen J. Wood, Christopher R. Bowie   +5 more
wiley   +1 more source